OC
TMO icon

Oarsman Capital’s Thermo Fisher Scientific TMO Stock Holding History

Oarsman Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Buy
582
+48
+9% +$23K 0.03% 194
2026
Q1 		$262K Sell
534
-24
-4% -$13K 0.03% 193
2025
Q4 		$323K Buy
558
+5
+0.9% +$2.83K 0.04% 174
2025
Q3 		$268K Sell
553
-11
-2% -$5.12K 0.04% 191
2025
Q2 		$229K Sell
564
-23
-4% -$9.62K 0.04% 222
2025
Q1 		$292K Sell
587
-24
-4% -$13K 0.05% 181
2024
Q4 		$318K Sell
611
-300
-33% -$165K 0.06% 172
2024
Q3 		$564K Buy
911
+32
+4% +$18.9K 0.1% 124
2024
Q2 		$486K Sell
879
-16
-2% -$9.17K 0.11% 128
2024
Q1 		$520K Buy
895
+26
+3% +$14.6K 0.12% 118
2023
Q4 		$461K Buy
869
+338
+64% +$164K 0.12% 129
2023
Q3 		$269K Buy
531
+41
+8% +$21.8K 0.11% 142
2023
Q2 		$256K Buy
490
+28
+6% +$15.1K 0.11% 144
2023
Q1 		$266K Buy
+462
New +$260K 0.12% 145

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Oarsman Capital's TMO Position: Q2 2026 in Review

Oarsman Capital increased its Thermo Fisher Scientific (TMO) stake by 9% in Q2 2026, buying an estimated $23K and bringing the position to 582 shares worth $292K. The position accounts for 0.03% of the portfolio, ranked #194.

Oarsman Capital first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. The position peaked at $564K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Oarsman Capital held 582 shares of Thermo Fisher Scientific worth $292K as of Q2 2026.
  • Oarsman Capital bought 48 Thermo Fisher Scientific shares in Q2 2026, an estimated $23K.
  • Thermo Fisher Scientific made up 0.03% of Oarsman Capital's portfolio in Q2 2026, its #194 holding.
  • Oarsman Capital first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
  • Oarsman Capital's Thermo Fisher Scientific position peaked at $564K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Oarsman Capital's 13F filing for Q2 2026, filed 7 Aug 2026.